# ![@cgoncology Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::2698910318.png) @cgoncology CG Oncology, Inc.

CG Oncology, Inc. posts on X about $cgon, we are, the first, cg oncology the most. They currently have [---] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: [--] [#](/creator/twitter::2698910318/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2698910318/c:line/m:interactions.svg)

- [--] Week [--] -44%
- [--] Month [---] -63%
- [--] Months [-----] -11%
- [--] Year [------] -74%

### Mentions: [--] [#](/creator/twitter::2698910318/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2698910318/c:line/m:posts_active.svg)

- [--] Week [--] -23%
- [--] Month [--] -58%
- [--] Months [--] +91%
- [--] Year [--] +136%

### Followers: [---] [#](/creator/twitter::2698910318/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2698910318/c:line/m:followers.svg)

- [--] Month [---] -0.22%
- [--] Months [---] +14%
- [--] Year [---] +20%

### CreatorRank: undefined [#](/creator/twitter::2698910318/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2698910318/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  43% [finance](/list/finance)  4% [countries](/list/countries)  4% [travel destinations](/list/travel-destinations)  2% [financial services](/list/financial-services)  1%

**Social topic influence**
[$cgon](/topic/$cgon) #19, [we are](/topic/we-are) 7%, [the first](/topic/the-first) 5%, [cg oncology](/topic/cg-oncology) 5%, [science](/topic/science) 3%, [business](/topic/business) 3%, [investment](/topic/investment) 3%, [in the](/topic/in-the) 2%, [morgan stanley](/topic/morgan-stanley) 2%, [check](/topic/check) 2%

**Top accounts mentioned or mentioned by**
[@kuanarthur](/creator/undefined) [@marktysonmd](/creator/undefined) [@urogerlimd](/creator/undefined) [@tbivala1](/creator/undefined) [@uroonc](/creator/undefined) [@garysteinbergmd](/creator/undefined) [@uroweb](/creator/undefined) [@abellete](/creator/undefined) [@svatekrob](/creator/undefined) [@naturemedicine](/creator/undefined) [@cgoncologys](/creator/undefined) [@siadaneshmand](/creator/undefined) [@pennmedicine](/creator/undefined) [@urologytimes](/creator/undefined) [@targetedonc](/creator/undefined) [@bladdercancerus](/creator/undefined) [@urodocash](/creator/undefined) [@mdandersonnews](/creator/undefined) [@simaporten](/creator/undefined) [@ucsfurology](/creator/undefined)

**Top assets mentioned**
[CG Oncology, Inc.  (CGON)](/topic/$cgon) [Morgan Stanley (MS)](/topic/morgan-stanley) [Goldman Sachs (GS)](/topic/goldman-sachs)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Staying laser-focused on what matters is key to driving impact for patients with bladder cancer. At CG Oncology Brian McGee helps shape the strategy behind our mission to advance novel oncolytic immunotherapies and bring new hope to patients. #CGsBetterTomorrow"  
[X Link](https://x.com/cgoncology/status/2009318930024943914)  2026-01-08T17:38Z [---] followers, [---] engagements


"Integrity guides everything we do at CG Oncology. We exemplify truthful trustworthy respectful and honorable collaboration and take pride in delivering on our commitment - whether advancing bladder-sparing immunotherapies or supporting patients. Learn more about #CGsBetterTomorrow: https://bit.ly/46qZP8k https://bit.ly/46qZP8k"  
[X Link](https://x.com/cgoncology/status/2011424232282956113)  2026-01-14T13:04Z [---] followers, [---] engagements


"Kristen Scholz leads CG Oncologys Medical Affairs team translating complex science into insights that help physicians make informed treatment decisions. With expertise in urologic cancer and a novel dual MOA CG is delivering innovative therapies for #bladdercancer patients. #CGsBetterTomorrow https://twitter.com/i/web/status/2001718283871859003 https://twitter.com/i/web/status/2001718283871859003"  
[X Link](https://x.com/anyuser/status/2001718283871859003)  2025-12-18T18:16Z [---] followers, [---] engagements


"For the team at CG Oncology collaboration fuels innovation - all in service of making #CGsBetterTomorrow. Our motivated and strategic team of more than [---] employees spans the globe and works across diverse functions sharing one mission: to advance bladder-sparing therapies for people living with bladder cancer. Kristen Michaelson is one of many employees who find joy and gratification in our work when collaborating with her colleagues. Learn more about our mission: https://bit.ly/46qZP8k https://bit.ly/46qZP8k"  
[X Link](https://x.com/anyuser/status/2003101516220014760)  2025-12-22T13:53Z [---] followers, [---] engagements


"From all of us at CG Oncology we wish you and your family a happy and healthy holiday season"  
[X Link](https://x.com/anyuser/status/2003481925114298694)  2025-12-23T15:04Z [---] followers, [--] engagements


"Today CG Oncology announced that Arthur Kuan @KuanArthur Chairman & Chief Executive Officer and Ambaw Bellete @abellete President & Chief Operating Officer will present at the 44th Annual J.P. Morgan Healthcare Conference on January [--] [----] at 8:15 am PT / 11:15 am ET. The conference is taking place at the Westin St. Francis San Francisco California. To learn more please read our release: https://bit.ly/4q9SDpK https://bit.ly/4q9SDpK"  
[X Link](https://x.com/anyuser/status/2008543400836948235)  2026-01-06T14:17Z [---] followers, [---] engagements


"Today CG Oncology announced an expedited timeline for the topline data readout now expected in the first half of [----] for the Phase [--] PIVOT-006 clinical trial comparing adjuvant intravesical cretostimogene grenadenorepvec versus surveillance in patients with intermediate-risk non-muscle invasive bladder cancer (IR NMIBC). PIVOT-006 is the first Phase [--] randomized trial in this patient population. Learn more: https://bit.ly/4pv9Toc https://bit.ly/4pv9Toc"  
[X Link](https://x.com/anyuser/status/2009620538713309609)  2026-01-09T13:37Z [---] followers, [---] engagements


"Today we honor Dr. Martin Luther King Jr.s powerful legacy. His leadership inspires us to build a workplace that embraces diversity elevates every voice and drives meaningful progress for our community. #MLKDay"  
[X Link](https://x.com/anyuser/status/2013235631455965546)  2026-01-19T13:02Z [---] followers, [---] engagements


"Today in honor of World Cancer Day we want to raise awareness around the [--] early warning signs of bladder cancer. Thanks to #BCAN for sharing this information and urging people with these changes to see a urologist promptly for proper evaluation. Learn more here: #WorldCancerDay #BladderCancer #EarlyDetection https://bcan.org/facing-bladder-cancer/bladder-cancer-signs-symptoms/ https://bcan.org/facing-bladder-cancer/bladder-cancer-signs-symptoms/"  
[X Link](https://x.com/anyuser/status/2019108393240220104)  2026-02-04T17:58Z [---] followers, [--] engagements


"👋 Hello #SanAntonio We're excited for #AUA24 Join @MarkTysonMD today 5/3 at 10:23 am CDT for updated BOND-003: Phase [--] study results of cretostimogene in the Stars at Night Ballroom. Afterwards meet the @CGOncology Medical Team at booth #100. ➡ http://auanet.org/AUA2024 http://auanet.org/AUA2024"  
[X Link](https://x.com/cgoncology/status/1786386575732994523)  2024-05-03T13:25Z [---] followers, [----] engagements


"#AUA24 is in full motion Visit @CGOncology at booth #100 to explore the mechanism of action (MoA) of cretostimogene in #VR. Dont miss Dr. Vijay Kasturi today at 12:30 pm CDT as he shares our advancements in #bladdercancer treatment. 🤝 http://auanet.org/AUA2024 http://auanet.org/AUA2024"  
[X Link](https://x.com/cgoncology/status/1786755156937228358)  2024-05-04T13:50Z [---] followers, [---] engagements


"We're thrilled to present our latest data today Join us to hear from @SvatekRob MD & @MarkTysonMD as they present on their respective ongoing trials: PIVOT-006 at 10:24 am and BOND-003 at 10:56 am CDT in the Learning Lab. Come join us 👉Full agenda: http://auanet.org/AUA2024 http://auanet.org/AUA2024"  
[X Link](https://x.com/cgoncology/status/1787111561896616371)  2024-05-05T13:26Z [---] followers, [---] engagements


"👏 #AUA24 was incredible We had a wonderful time connecting with colleagues and presenting our latest investigational data on cretostimogene alongside @MarkTysonMD and @SvatekRob MD. Explore our advances in the fight against #bladdercancer at http://CGOncology.com http://CGOncology.com"  
[X Link](https://x.com/cgoncology/status/1787918926665421017)  2024-05-07T18:54Z [---] followers, [---] engagements


"🔬 Learn more about the PIVOT-006 Phase [--] study of cretostimogene for intermediate-risk #NMIBC following #TURBT. Dr. Robert Svatek addresses the study's potential to transform the standard of care for #bladdercancer. 🎥 https://vimeo.com/938320040 https://vimeo.com/938320040"  
[X Link](https://x.com/cgoncology/status/1790804690600341640)  2024-05-15T18:01Z [---] followers, [---] engagements


"Unveiling our CORE-001 trial results tomorrow at #ASCO24 for BCG-unresponsive HR-#NMIBC Discover insights into safety efficacy and patient-reported outcomes. See how we aim to improve the entire spectrum of #bladdercancer care. @UrogerliMD @garysteinbergMD @TBivala1"  
[X Link](https://x.com/cgoncology/status/1796919647658213837)  2024-06-01T15:00Z [---] followers, [---] engagements


"#ICYMI: We recently announced the publication of our Phase [--] CORE-001 final study results of cretostimogene in combination w/pembrolizumab in @NatureMedicine for BCG-unresponsive HR-#NMIBC. @UrogerliMD @GarySteinbergMD @TBivala1 📄 See more details below: https://go.nature.com/4c6l9kz https://go.nature.com/4c6l9kz"  
[X Link](https://x.com/cgoncology/status/1800881615377403985)  2024-06-12T13:23Z [---] followers, [---] engagements


"Thank you @UrologyTimes for sharing @CGOncology's Expanded Access Program (EAP) for our novel oncolytic immunotherapy candidate cretostimogene. This program offers a potential pathway of hope for U.S. #patients w/BCG-unresponsive #NMIBC who meet eligibility criteria. See more: An expanded access program for cretostimogene grenadenorepvec has been initiated for patients in the US with BCG-unresponsive NMIBC. #blcsm #urology https://t.co/8WVkV6JtNk An expanded access program for cretostimogene grenadenorepvec has been initiated for patients in the US with BCG-unresponsive NMIBC. #blcsm #urology"  
[X Link](https://x.com/cgoncology/status/1803839482694598687)  2024-06-20T17:17Z [---] followers, [---] engagements


"Thank you to Targeted Oncology and Mark D. Tyson II MD MPH for sharing the encouraging results of the BOND-003 trial evaluating cretostimogene grenadenorepvec for BCG-Unresponsive HR #NMIBC @TargetedOnc @MarkTysonMD Read the article here: https://bit.ly/4d3aIi8 https://bit.ly/4d3aIi8"  
[X Link](https://x.com/cgoncology/status/1814033517740704221)  2024-07-18T20:24Z [---] followers, [---] engagements


"This week members of our executive team attended the Morgan Stanley 22nd Annual Global Healthcare Conference in New York. The team enjoyed sharing the latest updates on our pipeline at this important financial forum"  
[X Link](https://x.com/cgoncology/status/1832123069739229296)  2024-09-06T18:25Z [---] followers, [---] engagements


"Members of our Medical and Clinical Teams recently attended the Mid-Atlantic Sectional and New England Sections AUA meetings. The team enjoyed hearing about the latest advancements in urology and engaging with the community"  
[X Link](https://x.com/cgoncology/status/1833592029273854019)  2024-09-10T19:43Z [---] followers, [---] engagements


"Are you ready to make a difference in the world and become part of our patient-centered team that is focused on attacking bladder cancer for a better tomorrow Check out our job openings here: https://cgoncology.com/careers/ https://cgoncology.com/careers/"  
[X Link](https://x.com/cgoncology/status/1838289671329104240)  2024-09-23T18:49Z [---] followers, [---] engagements


"We also appreciate UroToday covering Dr. Dinney's presentation and urge you to check it out: https://www.urotoday.com/conference-highlights/ibcn-2024/155097-ibcn-2024-using-urinary-genomic-disease-burden-to-assess-cretostimogene-grenadenorepvec-preliminary-analysis-from-the-bond-003-trial.html https://www.urotoday.com/conference-highlights/ibcn-2024/155097-ibcn-2024-using-urinary-genomic-disease-burden-to-assess-cretostimogene-grenadenorepvec-preliminary-analysis-from-the-bond-003-trial.html"  
[X Link](https://x.com/cgoncology/status/1839388627840930141)  2024-09-26T19:36Z [---] followers, [---] engagements


"We recently joined together with patients care givers health care providers and other members of industry at the BCAN Summit in Philadelphia. Thanks to @BladderCancerUS for convening this important forum and welcoming us to participate"  
[X Link](https://x.com/cgoncology/status/1854527594349162675)  2024-11-07T14:13Z [---] followers, [---] engagements


"Hear from @UroDocAsh of @MDAndersonNews as he discusses the unmet need in the U.S. for a bladder-sparing therapy for patients who are unresponsive to or cannot access BCG. #BladderCancer #Urology"  
[X Link](https://x.com/cgoncology/status/1861424846606864498)  2024-11-26T15:00Z [---] followers, [---] engagements


"There were [-----] new cases of #bladdercancer in the U.S. in [----]. Our investigational drug cretostimogene grenadenorepvec is designed to treat patients with BCG-unresponsive #NMIBC which represents 75% of all new bladder cancer cases. Learn more: http://bit.ly/48IZnmi http://bit.ly/48IZnmi"  
[X Link](https://x.com/cgoncology/status/1861787214662730071)  2024-11-27T15:00Z [---] followers, [---] engagements


"Despite progress in #bladdercancer treatment several gaps persist in treating patients with High-Risk BCG-unresponsive #NMIBC. Hear from @SimaPorten Associate Professor in Residence at @UCSFUrology as she analyzes the current treatment landscape. #Urology"  
[X Link](https://x.com/cgoncology/status/1862527149707518248)  2024-11-29T16:00Z [---] followers, [---] engagements


"@siadaneshmand Director of Clinical Research @KeckMedicineUSC says the #bladdercancer community needs better treatment options. Our lead candidate cretostimogene grenadenorepvec has a novel MOA with the potential to fill this gap for patients if approved by the FDA. #Urology"  
[X Link](https://x.com/cgoncology/status/1863961547661267062)  2024-12-03T15:00Z [---] followers, [--] engagements


"In updated Phase [--] BOND-003 data shared at #SUO2024 cretostimogene grenadenorepvec showed sustained durable complete responses in high-risk BCG-unresponsive #NMIBC. See how CG Oncology is advancing innovation in the fight against #bladdercancer"  
[X Link](https://x.com/cgoncology/status/1864720545260146738)  2024-12-05T17:16Z [---] followers, 29.5K engagements


"New data shared at @UroOnc #SUO2024 highlights the potential of cretostimogene grenadenorepvec for BCG-unresponsive NMIBC if approved by the FDA. Learn more: #SUO #BladderCancer #Urology https://bit.ly/41fvcBG https://bit.ly/41fvcBG"  
[X Link](https://x.com/cgoncology/status/1864731611054358901)  2024-12-05T18:00Z [---] followers, [---] engagements


"Our team presented updated Phase [--] BOND-003 data on cretostimogene grenadenorepvec at #EAU25. The latest Phase [--] BOND-003 data reinforce cretostimogenes consistent efficacy favorable safety profile and durable response with no post-treatment precautions in BCG-unresponsive #NMIBC. See here for the full details of our late breaking abstract: @Uroweb #BladderCancer #Urology #CancerResearch #Immunotherapy #UroOncology https://bit.ly/4iC3JzW https://bit.ly/4iC3JzW"  
[X Link](https://x.com/cgoncology/status/1904142410533179599)  2025-03-24T12:05Z [---] followers, [---] engagements


"BCG therapy is often used to treat early-stage #bladdercancer. However a worldwide BCG shortage persists and up to 65% of patients either do not respond or eventually develop disease recurrence after first-line BCG therapy. Hear from @tbivala1 of @PennMedicine as he underscores the effects of the BCG shortages. Our lead investigational oncolytic immunotherapy candidate cretostimogene grenadenorepvec is designed with a dual mechanism of action to selectively replicate in and lyse cancer cells while simultaneously amplifying the immune response against bladder tumors. We believe cretostimogene"  
[X Link](https://x.com/cgoncology/status/1911767073975394427)  2025-04-14T13:02Z [---] followers, [---] engagements


"#BladderCancerAwarenessMonth #DidYouKnow #FactFriday"  
[X Link](https://x.com/cgoncology/status/1920831139347915105)  2025-05-09T13:20Z [---] followers, [---] engagements


"Check out this article in @FierceHealth to learn more about how if approved our lead investigational candidate cretostimogene grenadenorepvec could redefine the standard of care for non-muscle invasive bladder cancer (#NMIBC): https://bit.ly/3SxhbJT https://bit.ly/3SxhbJT"  
[X Link](https://x.com/cgoncology/status/1921971901984883126)  2025-05-12T16:53Z [---] followers, [---] engagements


"#BladderCancerAwarenessMonth #DidYouKnow #FactFriday"  
[X Link](https://x.com/cgoncology/status/1923346822518431943)  2025-05-16T11:56Z [---] followers, [--] engagements


"#BladderCancerAwarenessMonth #DidYouKnow #FactFriday"  
[X Link](https://x.com/cgoncology/status/1928424287884484927)  2025-05-30T12:12Z [---] followers, [--] engagements


"Today is National Cancer Survivors Day which honors anyone living with a history of cancer - from the moment of diagnosis through the remainder of life. Together let us bring attention to the ongoing challenges that cancer survivors face and celebrate life. #NCSD2025"  
[X Link](https://x.com/cgoncology/status/1929155105414172883)  2025-06-01T12:36Z [---] followers, [---] engagements


"Earlier this week our Chairman & Chief Executive Officer Arthur Kuan participated in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami Beach FL. Thanks to #GoldmanSachs for the opportunity to talk about our progress towards developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer"  
[X Link](https://x.com/cgoncology/status/1932858951416086551)  2025-06-11T17:54Z [---] followers, [---] engagements


"Last week our team was honored to participate in the annual BCAN Bladder Cancer Think Tank Meeting in Washington D.C. Thank you to #BCAN for convening such an important and impactful forum"  
[X Link](https://x.com/cgoncology/status/1952812378560631233)  2025-08-05T19:22Z [---] followers, [---] engagements


"Today we honor the strength resilience and dedication of workers everywhere. We want to especially recognize our employees who come to work every day with purpose and passion to innovate on behalf of bladder cancer patients - the work you do matters"  
[X Link](https://x.com/cgoncology/status/1962484519929291087)  2025-09-01T11:55Z [---] followers, [---] engagements


"Today our CEO Arthur Kuan and our President & COO Ambaw Bellete participated in a fireside chat at the Cantor Global Healthcare Conference. Thanks to Josh Schimmer M.D. for facilitating such a great discussion. https://ir.cgoncology.com/events/event-details/cantor-global-healthcare-conference https://ir.cgoncology.com/events/event-details/cantor-global-healthcare-conference"  
[X Link](https://x.com/cgoncology/status/1964054976587596000)  2025-09-05T19:56Z [---] followers, [---] engagements


"Just a few days until @UroOnc #SUO2024 in Dallas Were excited to share updates on cretostimogene grenadenorepvecs potential to advance bladder cancer treatment if approved by the FDA. Catch our presentation on 12/5 at 11:45: #SUO24 #SUO #Urology https://bit.ly/4ir7o42 https://bit.ly/4ir7o42"  
[X Link](https://x.com/cgoncology/status/1863589531137847634)  2024-12-02T14:22Z [---] followers, [----] engagements


"CG Oncology is proud to participate in the European Society of Medical Oncology Congress #ESMO24 this week in Barcelona to learn about the latest advances in oncology research and to engage with members of the global oncology community"  
[X Link](https://x.com/cgoncology/status/1835772341726400780)  2024-09-16T20:06Z [---] followers, [---] engagements


"Today CG Oncology announced Nature Medicine's publication of phase 1b study results evaluating cretostimogene in combination with nivolumab in MIBC as well as the simultaneous presentation at SITC. Check out the release here: https://ir.cgoncology.com/news-releases/news-release-details/cg-oncology-announces-nature-medicine-publication-phase-1b-study https://ir.cgoncology.com/news-releases/news-release-details/cg-oncology-announces-nature-medicine-publication-phase-1b-study"  
[X Link](https://x.com/cgoncology/status/1855960722259194356)  2024-11-11T13:08Z [---] followers, [---] engagements


"CG Oncology attended #ASCOGU25 and learned about the latest high-impact science multidisciplinary expertise and evidence-based practices. We also connected with urologists medical oncologists and advocates on our candidate cretostimogene grenadenorepvec #Bladdercancer #NMIBC"  
[X Link](https://x.com/cgoncology/status/1890818572835848481)  2025-02-15T17:40Z [---] followers, [---] engagements


"This month CG Oncology joins the entire urology community in honoring September as Urological Cancer Awareness Month. To learn more visit the Urology Foundation at https://www.theurologyfoundation.org/impact-achievements/campaigns/uam2024/ https://www.theurologyfoundation.org/impact-achievements/campaigns/uam2024/"  
[X Link](https://x.com/cgoncology/status/1831009577703248199)  2024-09-03T16:41Z [---] followers, [---] engagements


"At the [----] International Bladder Cancer Network Annual Meeting Dr. Colin Dinney MD Anderson Cancer Center presented the first translational research for CG Oncology's BOND-003Phase [--] Study evaluating its investigational oncolytic immunotherapy cretostimogene grenadenorepvec"  
[X Link](https://x.com/cgoncology/status/1839388625437708586)  2024-09-26T19:36Z [---] followers, [---] engagements


"Thanks to #SIU2024NewDelhi for the opportunity to provide updates on CG Oncology's investigational intravesically delivered oncolytic immunotherapy cretostimogene grenadenorepvec and toDrs Piyush Agarwal @siadaneshmand @spsutkaMD @MarkTysonMD for their TIP presentations"  
[X Link](https://x.com/cgoncology/status/1850928720598425996)  2024-10-28T15:52Z [---] followers, [---] engagements


"CG Oncology is gearing up for @UroOnc #SUO2024 in Dallas from Dec. 4-6 Dont miss our Phase [--] BOND-003 data presentation on 12/5. Connect with us to learn more about our lead candidate cretostimogene grenadenorepvec. View the agenda: #SUO #Urology http://bit.ly/4fCfm7Y http://bit.ly/4fCfm7Y"  
[X Link](https://x.com/cgoncology/status/1861113928685592810)  2024-11-25T18:25Z [---] followers, [---] engagements


"Members of the CG Oncology team are headed to Madrid Spain for #EAU25. Join us for a series of key presentations and updates including late-breaking clinical and first translational data from BOND-003 Cohort C. Read more about our presentations: @Uroweb #BladderCancer #Urology #UroOncology https://twitter.com/i/web/status/1899794170761412815 https://bit.ly/3DDA4ah https://twitter.com/i/web/status/1899794170761412815 https://bit.ly/3DDA4ah"  
[X Link](https://x.com/cgoncology/status/1899794170761412815)  2025-03-12T12:06Z [---] followers, [---] engagements


"The CG Oncology team is gearing up for an exciting #AUA25 We will share durability results from Phase [--] BOND-003 on cretostimogene grenadenorepvec as part of a Practice-changing Paradigm-shifting Clinical Trials in Urology (P2s) session at @AmerUrologicals [----] Annual Meeting in Las Vegas NV from April 26-29. We will also present three updates to ongoing clinical trials expected to influence #urology practice and one interactive poster on translational data. See the full presentation details here: #BladderCancer #UroOncology https://bit.ly/3FP9dZK"  
[X Link](https://x.com/cgoncology/status/1906679224976494989)  2025-03-31T12:05Z [---] followers, [---] engagements


"Join us on Monday April [--] for a conference call and webcast to discuss the latest BOND-003 Cohort C and Cohort P data presented at #AUA2025. Details: #Urology #UroOncology #BladderCancer #CancerResearch https://bit.ly/3YaQMoD https://bit.ly/3YaQMoD"  
[X Link](https://x.com/cgoncology/status/1915409201095917729)  2025-04-24T14:15Z [---] followers, [---] engagements


"At CG Oncology we are passionate about innovating on behalf of bladder cancer patients. In honor of #BladderCancerAwarenessMonth we will be sharing a series of #DidYouKnow facts every Friday to help raise awareness close the gap and make sure everyone knows the facts"  
[X Link](https://x.com/cgoncology/status/1917928968944275650)  2025-05-01T13:07Z [---] followers, [---] engagements


"At CG Oncology we honor the men and women who made the ultimate sacrifice for our freedom today and always"  
[X Link](https://x.com/cgoncology/status/1926977517904109794)  2025-05-26T12:23Z [---] followers, [---] engagements


"Happy #PrideMonth At CG Oncology we believe our differences make us stronger. We are proud to foster an inclusive and welcoming community for all"  
[X Link](https://x.com/cgoncology/status/1929233419751325941)  2025-06-01T17:47Z [---] followers, [---] engagements


"Today we announced updated data on BOND-003 Cohort C. Learn more here: #BladderCancer #Urology #UroOncology http://bit.ly/460VhoQ http://bit.ly/460VhoQ"  
[X Link](https://x.com/cgoncology/status/1963932276443521388)  2025-09-05T11:48Z [---] followers, [---] engagements


"Our executives are back on the road to share CG Oncology's significant progress towards delivering on our mission. Thanks to @MorganStanley for inviting @KuanArthur and @abellete to participate in a fireside chat. #BladderCancer #Urology #UroOncology https://ir.cgoncology.com/events/event-details/morgan-stanley-23rd-annual-global-healthcare-conference https://ir.cgoncology.com/events/event-details/morgan-stanley-23rd-annual-global-healthcare-conference"  
[X Link](https://x.com/cgoncology/status/1965471963956314549)  2025-09-09T17:46Z [---] followers, [---] engagements


"Were kicking off our Team Behind a Better Tomorrow campaign spotlighting the people and values that make CG a great place to work. From caregiver to Chief of Staff Calvin Lais journey at CG Oncology has been shaped by his personal experience having a loved one with bladder cancer. [--] years later he drives strategic priorities aligned to our mission: advancing bladder-sparing treatments for patients and families. #CGsBetterTomorrow https://twitter.com/i/web/status/1988614190890639379 https://twitter.com/i/web/status/1988614190890639379"  
[X Link](https://x.com/cgoncology/status/1988614190890639379)  2025-11-12T14:25Z [---] followers, [---] engagements


"#Perseverance is at the heart of CG Oncology. Drew Darker a military veteran and our commercial launch & OPEX lead brings determination and creativity to deliver better outcomes for patients every day. Learn more about CGONs values: #CGsBetterTomorrow https://twitter.com/i/web/status/1991518636457046273 https://bit.ly/46qZP8k https://twitter.com/i/web/status/1991518636457046273 https://bit.ly/46qZP8k"  
[X Link](https://x.com/cgoncology/status/1991518636457046273)  2025-11-20T14:46Z [---] followers, [--] engagements


"Were excited to be at the #SUO25 Annual Meeting CG Oncology will present [--] late-breaking podium presentations and [--] posters further supporting cretostimogene as a potential backbone therapy for a broad range of #NMIBC patients. #BladderCancer #Urology #Oncology #NMIBC #HeathcareInnovation #BladderCancerResearch #OncolyticImmunotherapy https://twitter.com/i/web/status/1996611846967861260 https://twitter.com/i/web/status/1996611846967861260"  
[X Link](https://x.com/cgoncology/status/1996611846967861260)  2025-12-04T16:05Z [---] followers, [---] engagements


"At CG Oncology we envision a world where patients with bladder cancer live with dignity and an improved quality of life. Therefore we are eager to share our progress towards this goal and we recently launched an updated corporate website where you can find the latest information. Please swing by to learn more. Enjoy #SUO25 #BladderCancer #Urology #Oncology #NMIBC #HeathcareInnovation #BladderCancerResearch #OncolyticImmunotherapy http://cgoncology.com http://cgoncology.com"  
[X Link](https://x.com/cgoncology/status/1996698306630795303)  2025-12-04T21:49Z [---] followers, [---] engagements


"Cold Genesys Announces Name Change to CG Oncology https://www.businesswire.com/news/home/20200325005060/en/Cold-Genesys-Announces-Change-CG-Oncology https://www.businesswire.com/news/home/20200325005060/en/Cold-Genesys-Announces-Change-CG-Oncology"  
[X Link](https://x.com/cgoncology/status/1242784532668887040)  2020-03-25T12:04Z [---] followers, [--] engagements


"CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co. Ltd. for CG0070 in Japan and Other Asian Countries https://www.businesswire.com/news/home/20200326005259/en/CG-Oncology-Announces-License-Commercialization-Agreement-Kissei https://www.businesswire.com/news/home/20200326005259/en/CG-Oncology-Announces-License-Commercialization-Agreement-Kissei"  
[X Link](https://x.com/cgoncology/status/1243327573016211457)  2020-03-27T00:02Z [---] followers, [--] engagements


"Excited to announce our clinical trial collaboration with @bmsnews to evaluate our oncolytic immunotherapy CG0070 with OPDIVO in metastatic #urothelialcancer #bladdercancer #immunotherapy Read our press release here: https://cutt.ly/bWK7HZB https://cutt.ly/bWK7HZB"  
[X Link](https://x.com/cgoncology/status/1435954206372941829)  2021-09-09T13:12Z [---] followers, [--] engagements


"Excited to announce our collaboration with @Roche on a Clinical Trial of #Oncolytic #Immunotherapy CG0070 as Part of Novel Combination for Various Solid Tumor Indications #cancer #oncology @KuanArthur https://bwnews.pr/3kwTYYa https://bwnews.pr/3kwTYYa"  
[X Link](https://x.com/cgoncology/status/1440649198039228430)  2021-09-22T12:08Z [---] followers, [--] engagements


"Check out 👉Building Biotech: CG Oncology CEO Arthur Kuan with @KuanArthur @cgoncology @Jack_O_Meara @nabsicle and DNA Tie Club. Sunday Sep [--] at 10:00 AM PDT in @clubhouse #oncology http://clubhouse.com/event/PAak9wJA http://clubhouse.com/event/PAak9wJA"  
[X Link](https://x.com/cgoncology/status/1441390939017121796)  2021-09-24T13:15Z [---] followers, [--] engagements


"Excited to share this never before seen data in #bladdercancer presented by @UrogerliMD at @sitcancer 100% of Patients Evaluable for Efficacy (N=9) Achieved Complete Response (CR) at the Initial 3-Month Timepoint #oncolytic #immunotherapy @KuanArthur https://bwnews.pr/30kyxT6 https://bwnews.pr/30kyxT6"  
[X Link](https://x.com/cgoncology/status/1459590808814895106)  2021-11-13T18:35Z [---] followers, [--] engagements


"Excited to share the first patient has been dosed in Japan in our Phase [--] Monotherapy Study of CG0070 in Non-Muscle-Invasive #BladderCancer Unresponsive to Bacillus Calmette-Guerin @kisseipharma 🔥🔥👇 Read more here: 👇👇👇 #immunotherapy https://bwnews.pr/3J2vtwd https://bwnews.pr/3J2vtwd"  
[X Link](https://x.com/cgoncology/status/1472918249918586892)  2021-12-20T13:14Z [---] followers, [--] engagements


"📄Phase [--] CORE-001 Final Results: Cretostimogene in combination w/pembrolizumab for BCG-unresponsive HR-#NMIBC showed a 54% (19/35) complete response (CR) rate at [--] months. Poster will be presented at #ASCO24 @UrogerliMD @GarySteinbergMD @TBivala1 https://bit.ly/3QZhf4T https://bit.ly/3QZhf4T"  
[X Link](https://x.com/cgoncology/status/1793987886355972502)  2024-05-24T12:50Z [---] followers, [----] engagements


"🏙 Heading to #ASCO24 Our #patientcentric approach addresses all stages of #bladdercancer w/innovative #immunotherapies. Hear the final results of our CORE-001 Phase [--] trial showcasing our commitment to improving patient outcomes & transforming care. 🔗 https://bit.ly/3QZhf4T https://bit.ly/3QZhf4T"  
[X Link](https://x.com/cgoncology/status/1795938510442020896)  2024-05-29T22:01Z [---] followers, [---] engagements


"Were on the ground at the 40th Annual European Association of Urology (EAU) Congress to share a series of key presentations and updates on our lead candidate cretostimogene grenadenorepvec On Monday March [--] dont miss @tbivala1 of @PennMedicine presenting the latest clinical and translational data from BOND-003 Cohort C. More details: @Uroweb #BladderCancer #Urology #UroOncology https://bit.ly/3DDA4ah https://bit.ly/3DDA4ah"  
[X Link](https://x.com/cgoncology/status/1903118912285180082)  2025-03-21T16:18Z [---] followers, [---] engagements


"#AUA2025 is just around the corner In a few days we will be in fabulous Las Vegas for the @AmerUrological (AUA) [----] Annual Meeting. Join us for series of key presentations and updates to clinical trials evaluating our lead candidate cretostimogene grenadenorepvec across the non-muscle invasive bladder cancer (#NMIBC) treatment landscape. We will also present durability results from the Phase [--] BOND-003 trial presented as a late breaker in AUAs Practice-changing Paradigm-shifting Clinical Trials in Urology session. More details: #BladderCancer #UroOncology #Urology https://bit.ly/3FP9dZK"  
[X Link](https://x.com/cgoncology/status/1914677142878671082)  2025-04-22T13:46Z [---] followers, [----] engagements


"New BOND-003 data presented at #AUA25 reinforce cretostimogenes potential in BCG-unresponsive #NMIBC. Learn how data from Cohorts P and C build upon the body of clinical evidence on cretostimogene demonstrating compelling response rates and sustained durability. https://bit.ly/4jsm6aP https://bit.ly/4jsm6aP"  
[X Link](https://x.com/cgoncology/status/1916231766656094352)  2025-04-26T20:43Z [---] followers, [---] engagements


"As we close out bladder health week it is especially timely to share an update on our tremendous progress towards. We've made significant strides most notably the BLA filing submission of cretostimogene for our lead indication of HR BCG-unresponsive NMIBC with CIS with or without Ta/T1 disease. #BladderCancer #Urology #UroOncology https://bit.ly/4i5NkVa https://bit.ly/4i5NkVa"  
[X Link](https://x.com/cgoncology/status/1989319648395858237)  2025-11-14T13:08Z [---] followers, [---] engagements


"Were developing bladder-sparing therapies to help patients find freedom from the daily burdens of bladder cancer. Our CMO Vijay draws on his experience as a physician and caregiver to guide our mission and advance therapies that truly make a difference. Learn more about our vision: #CGsBetterTomorrow https://bit.ly/3IlT0gb https://bit.ly/3IlT0gb"  
[X Link](https://x.com/cgoncology/status/1990794521647415672)  2025-11-18T14:49Z [---] followers, [---] engagements


"For Maurice Garland purposeful work means helping a team unite to improve the lives of #bladdercancer patients. On the Market Access team he works with payers and ensures fair and accessible pricing for the community we serve. #CGsBetterTomorrow"  
[X Link](https://x.com/cgoncology/status/1992981805822341472)  2025-11-24T15:41Z [---] followers, [--] engagements


"For Maurice Garland purposeful work means helping a team unite to improve the lives of #bladdercancer patients. On the Market Access team he works with payers and ensures fair and accessible pricing for the community we serve. #CGsBetterTomorrow"  
[X Link](https://x.com/cgoncology/status/1993015577729024061)  2025-11-24T17:55Z [---] followers, [--] engagements


"We are delighted to welcome accomplished life sciences executive Christina Rossi to our Board of Directors"  
[X Link](https://x.com/cgoncology/status/1993652385177071931)  2025-11-26T12:05Z [---] followers, [--] engagements


"We are officially one dayout from @UroOnc #SUO2025 in Phoenix And we are thrilled to have the opportunity to share the very latest clinical data on our lead candidate cretostimogene grenadenorepvec for non-muscle invasive bladder cancer with two late-breaking presentations slated for the agenda this year as well as posters. See more detail below and here: Hope to see you there #SUO25 #SUO #Urology #BladderCancer https://bit.ly/4rjQo3R https://bit.ly/4rjQo3R"  
[X Link](https://x.com/cgoncology/status/1995518597855154662)  2025-12-01T15:41Z [---] followers, [---] engagements


"With two decades of experience in biotech and contributions to multiple commercialized products Sarah Connors leads communications and advocacy at CG Oncology. Sarah plays a pivotal role in shaping and sharing CG Oncologys story with key internal and external stakeholders always anchored in addressing the significant unmet need for innovative bladder-sparing treatment options. #CGsBetterTomorrow"  
[X Link](https://x.com/cgoncology/status/1999109573362245930)  2025-12-11T13:30Z [---] followers, [--] engagements


"Today CG Oncology announced that Arthur Kuan Chairman & Chief Executive Officer and Ambaw Bellete President & Chief Operating Officer will present at the 44th Annual J.P. Morgan Healthcare Conference on January [--] [----] at 8:15 am PT / 11:15 am ET. The conference is taking place at the Westin St. Francis San Francisco California. To learn more please read our release: https://bit.ly/4q9SDpK https://bit.ly/4q9SDpK"  
[X Link](https://x.com/cgoncology/status/2008536231626285193)  2026-01-06T13:48Z [---] followers, [--] engagements


"Today we announced our [----] year end financial results. We also provided business updates for the investment community. Details: #BladderCancer #Urology #UroOncology https://bit.ly/4jaGpt6 https://bit.ly/4jaGpt6"  
[X Link](https://x.com/cgoncology/status/1905590711170597115)  2025-03-28T12:00Z [---] followers, [---] engagements


"We're on the same page as @PGrivasMDPhD Clinical Director of Genitourinary Cancers Program at @fredhutch and Associate Professor of Oncology at the @UW that collaboration is an essential part of #drugdevelopment. At CG Oncology we see a world where urologic cancer patients can benefit from innovative oncolytic immunotherapies to live with dignity and have an enhanced quality of life. That is why were committed to working with the #UroOncology community to develop cretostimogene grenadenorepvec a potential backbone bladder-sparing therapeutic for patients with #bladdercancer. Join us at #AUA25"  
[X Link](https://x.com/cgoncology/status/1912506018002596342)  2025-04-16T13:59Z [---] followers, [---] engagements


"Today we announced our financial results for the first quarter. We also provided business updates for the investment community. Details: #BladderCancer #Urology #UroOncology https://bit.ly/42Xm59a https://bit.ly/42Xm59a"  
[X Link](https://x.com/cgoncology/status/1922263550828978405)  2025-05-13T12:11Z [---] followers, [---] engagements


"The [----] ASCO Annual Meeting is focused on driving cancer research into actionable change - that really resonates with our team here at CG Oncology. #ASCO2025 #CGOncology #BladderCancerCommunity #BCAN"  
[X Link](https://x.com/cgoncology/status/1929525178024775985)  2025-06-02T13:07Z [---] followers, [---] engagements


"Today we announced our financial results for the second quarter. We also provided business updates for the investment community. Details: #BladderCancer #Urology #UroOncology http://bit.ly/46SHtip http://bit.ly/46SHtip"  
[X Link](https://x.com/cgoncology/status/1953790625901375996)  2025-08-08T12:09Z [---] followers, [---] engagements


"👏 We're excited to share the publication of the final results of our CORE-001 Phase [--] trial of cretostimogene in combination w/pembrolizumab are available in @NatureMedicine. Co-authored by @UrogerliMD this study advances treatment options for #NMIBC. https://ir.cgoncology.com/news-releases/news-release-details/cg-oncology-announces-nature-medicine-publication-final-results https://ir.cgoncology.com/news-releases/news-release-details/cg-oncology-announces-nature-medicine-publication-final-results"  
[X Link](https://x.com/cgoncology/status/1798759499802743097)  2024-06-06T16:50Z [---] followers, [----] engagements


"We're pleased to announce @CGOncology's Expanded Access Program (EAP) for cretostimogene grenadenorepvec in the U.S. https://bit.ly/3Rv5a7C https://bit.ly/3Rv5a7C"  
[X Link](https://x.com/cgoncology/status/1803035477953466709)  2024-06-18T12:02Z [---] followers, [---] engagements


"CG Oncology congratulates Drs. Saum Ghodoussipour Rutgers Cancer Institute of New Jersey and Taylor Goodstein M.D. Emory University - recipients for the first annual Non-Muscle Invasive Bladder Cancer (NMIBC) CG-SUO-CTC NMIBC Research Fellowship. https://bit.ly/4d7z9fK https://bit.ly/4d7z9fK"  
[X Link](https://x.com/cgoncology/status/1917982450401288530)  2025-05-01T16:40Z [---] followers, [---] engagements


"Today we announced that we completed enrollment in our PIVOT-006 study. Thank you to the SUO-CTC for their support to all participating trial sites for their dedication and most importantly to the patients who make this research possible. Details: #BladderCancer #Urology #UroOncology http://bit.ly/45TegS0 https://twitter.com/i/web/status/1963228171987263499 http://bit.ly/45TegS0 http://bit.ly/45TegS0 https://twitter.com/i/web/status/1963228171987263499 http://bit.ly/45TegS0"  
[X Link](https://x.com/cgoncology/status/1963228171987263499)  2025-09-03T13:10Z [---] followers, [---] engagements


"As a cancer survivor Elaine Harris is driven to leverage her understanding of the patients journey to innovate and find solutions. At CG Oncology we are relentlessly driven to deliver novel oncolytic immunotherapies (OITs) to those who need them most. Learn more about our values: #CGsBetterTomorrow https://bit.ly/46qZP8k https://twitter.com/i/web/status/1989363603577901467 https://bit.ly/46qZP8k https://twitter.com/i/web/status/1989363603577901467"  
[X Link](https://x.com/cgoncology/status/1989363603577901467)  2025-11-14T16:03Z [---] followers, [---] engagements


"The team at CG Oncology is looking forward to returning to this years @UroOnc #SUO2025 early next month. We are proud to have two late-breaking abstracts selected for the conference: topline results from Cohort P of our BOND-003 trial and first results from Cohort A of our CORE-008 trial both evaluating our lead candidate cretostimogene grenadenorepvec in non-muscle invasive bladder cancer patients. See our press release here for more information on our late-breakers and our posters at SUO: See you in Phoenix Dec. 2-5 #SUO #Urology #BladderCancer #Oncology #CGOncology https://bit.ly/4rjQo3R"  
[X Link](https://x.com/cgoncology/status/1993426213508190596)  2025-11-25T21:07Z [---] followers, [---] engagements


"We prioritize well-being at CG Oncology by creating an environment where our team can grow stay refreshed and focused on delivering the best care for #bladdercancer patients. Learn more about our values: #CGsBetterTomorrow https://bit.ly/46qZP8k https://bit.ly/46qZP8k"  
[X Link](https://x.com/cgoncology/status/2000933632496845244)  2025-12-16T14:18Z [---] followers, [---] engagements


"At #SUO25 Dr. Rob Svatek joinsas a new member of TeamCGON bringing years of experience as a bladder cancer surgeon and researcher including leading numerous early and late phase clinical trials and running an NIH R01-funded bladder cancer immunology laboratory. His mission: help more patients preserve their bladder and quality of life. This mission is what brought him to CG Oncology as our new VP of Clinical Development. As an investigator in our trials including PIVOT-006which completed enrollment nearly a year early he saw firsthand the potential of cretostimogene to offer a new therapeutic"  
[X Link](https://x.com/anyuser/status/1995902604790874617)  2025-12-02T17:07Z [---] followers, [---] engagements


"Today we announced topline data from BOND-003 Cohort P and first results from CORE-008 Cohort A which demonstrated promising efficacy safety and tolerability. These data will be presented later today as Late-Breaking Abstracts at the Society of Urologic Oncology (SUO) 26th Annual Meeting. To learn more please read our press release: https://bit.ly/3XzcqST https://bit.ly/3XzcqST"  
[X Link](https://x.com/anyuser/status/1996940422686691787)  2025-12-05T13:51Z [---] followers, [---] engagements


"For members of the bladder cancer community in attendance at the Society of Urologic Oncology (SUO) 26th Annual Meeting taking place at the Sheraton Phoenix Downtown please be sure to check out our Late Breaking presentations. Details on the presentations are outlined below and you can find more information on our data in today's press release: https://bit.ly/3XzcqST https://bit.ly/3XzcqST"  
[X Link](https://x.com/anyuser/status/1997027648028258358)  2025-12-05T19:37Z [---] followers, [---] engagements


"At CG #bladdercancer patients are at the heart of everything we do. Our Sr. Director of Scientific Comms Shelja Patel helps turn complex science into meaningful information for patients and providers driving our mission to deliver more options and a better quality of life for patients. Learn more about CGs values: #CGsBetterTomorrow https://bit.ly/46qZP8k https://bit.ly/46qZP8k"  
[X Link](https://x.com/anyuser/status/1998399981196042263)  2025-12-09T14:30Z [---] followers, [---] engagements


"With two decades of experience in biotech and contributions to multiple commercialized products Sarah Connors leads communications and advocacy at CG Oncology. Sarah plays a pivotal role in shaping and sharing CG Oncologys story with key internal and external stakeholders always anchored in addressing the significant unmet need for innovative bladder-sparing treatment options. #CGsBetterTomorrow https://twitter.com/i/web/status/1999147929978708374 https://twitter.com/i/web/status/1999147929978708374"  
[X Link](https://x.com/anyuser/status/1999147929978708374)  2025-12-11T16:03Z [---] followers, [---] engagements


"The CG-SUO-CTC NMIBC Research Fellowship is designed to support the development of outstanding clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of NMIBC. Learn more here: https://bit.ly/4j4pXLR https://bit.ly/4j4pXLR"  
[X Link](https://x.com/anyuser/status/2001654032256086034)  2025-12-18T14:01Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing